Sage Journals: Discover world-class research

Open access

Review article

First published 2023-7

M pro -targeted anti-SARS-CoV-2 inhibitor-based drugs

Zhuxin She, Yinuo Yao, Conglong Wang [...]

Journal of Chemical Research

Free access

Research article

First published 2018-2

Cell Density Affects the Detection of Chk1 Target Engagement by the Selective Inhibitor V158411

Clara C. Geneste, Andrew J. Massey

Journal of Biomolecular Screening

Retricted access

Review article

First published 2011-4-22

Membrane Anchored and Lipid Raft Targeted β-Secretase Inhibitors for Alzheimer's Disease Therapy

Saoussen Ben Halima, Lawrence Rajendran

Journal of Alzheimer’s Disease

Open access

Review article

First published 2025

The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond

Alice Bernard-Tessier, Natacha Naoun, Solenn Barraud [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020

Tuberculosis and targeted synthetic or biologic DMARDs,beyond tumor necrosis factor inhibitors

Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2021

Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment

Ze-Long Liu, Jing-Hua Liu, Daniel Staiculescu [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2014-9

Congenital Segmental Lymphedema in Tuberous Sclerosis Complex With Associated Subependymal Giant Cell Astrocytomas Treated with Mammalian Target of Rapamycin Inhibitors

Giulia Prato, Maria Margherita Mancardi, Maria Giuseppina Baglietto [...]

Journal of Child Neurology

Retricted access

Research article

First published 2019-3

Treating to Target(s) With Interleukin-17 Inhibitors

Charles W. Lynde, Jennifer Beecker, Jan Dutz [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2017-3

Mammalian target of rapamycin inhibitors,temsirolimus and torin 1,attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells

Goparaju Chandrika, Kumar Natesh, Deepak Ranade [...]

Tumor Biology

Retricted access

Research article

First published 2026

Immortal time bias in contemporary CDK4/6 inhibitor studies: Evidence from target trial emulation

G. Hari Prakash, Sunil Kumar, Kiran PK [...]

Journal of Oncology Pharmacy Practice

Search results